Edition:
United States

ICU Medical Inc (ICUI.OQ)

ICUI.OQ on NASDAQ Stock Exchange Global Select Market

169.60USD
16 Aug 2017
Change (% chg)

-- (--)
Prev Close
$169.60
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
49,719
52-wk High
$176.50
52-wk Low
$120.66

Latest Key Developments (Source: Significant Developments)

Medical Australia enters scheme implementation agreement
Wednesday, 9 Aug 2017 07:14pm EDT 

Aug 10 (Reuters) - Medical Australia Ltd :Entered scheme implementation agreement under which it is proposed that ICU Medical Inc will acquire MLA.ICU Medical will acquire all ordinary shares in MLA by way of scheme of arrangement.MLA shareholders will be entitled to receive A$0.086 cash per share.MLA board recommends scheme and recommends MLA shareholders vote in favour of scheme in absence of superior proposal.  Full Article

ICU Medical reports Q2 loss per share $1.87
Wednesday, 9 Aug 2017 04:05pm EDT 

Aug 10 (Reuters) - ICU Medical Inc -:ICU Medical Inc announces second quarter 2017 results.Q2 adjusted earnings per share $0.76.Q2 gaap loss per share $1.87.Q2 revenue $331.5 million versus I/B/E/S view $318.3 million.Q2 earnings per share view $0.77 -- Thomson Reuters I/B/E/S.ICU Medical Inc says modifying its full year 2017 guidance for adjusted earnings per share from a range of $3.55 to $3.90 to a range of $3.80 to $4.20.FY2017 earnings per share view $4.14 -- Thomson Reuters I/B/E/S.  Full Article

ICU Medical announces Q1 revenue $247.7 million
Wednesday, 10 May 2017 04:05pm EDT 

May 10 (Reuters) - ICU Medical Inc :ICU Medical, Inc. announces first quarter 2017 results.Q1 adjusted earnings per share $1.68.Q1 revenue $247.7 million versus I/B/E/S view $237.1 million.Q1 GAAP earnings per share $2.86.Q1 earnings per share view $0.46 -- Thomson Reuters I/B/E/S.  Full Article

ICU Medical receives grand jury subpoena issued by U.S. District Court
Tuesday, 18 Apr 2017 05:21pm EDT 

April 18 (Reuters) - ICU Medical Inc -:ICU Medical- on april 18, received grand jury subpoena issued by u.s. District court for eastern district of pennsylvania - sec filing.ICU Medical- subpoena calls for production of documents regarding manufacturing, selling, pricing of intravenous solutions sold by co.ICU Medical Inc - grand jury subpoena received in connection with an investigation by u.s. Department of justice, antitrust division.ICU Medical - subpoena also calls for production of communications with competitors regarding intravenous solutions.ICU Medical - subpoena received in connection with hospira infusion systems business that icu medical, inc. Acquired in feb 2017 from pfizer, inc..  Full Article

Icu Medical Inc announces Q4 adj earnings per share $1.20
Wednesday, 1 Mar 2017 04:05pm EST 

Icu Medical Inc : Icu Medical Inc announces fourth quarter and fiscal year 2016 results . Q4 adjusted earnings per share $1.20 . Q4 gaap earnings per share $0.54 . Q4 revenue $95.7 million versus I/B/E/S view $94.4 million . Q4 earnings per share view $1.19 -- Thomson Reuters I/B/E/S . Says for 2017, expects revenue to be in range of $1.2 billion to $1.25 billion; adjusted earnings per share to be in range of $3.55 to $3.90 .FY2017 earnings per share view $3.97, revenue view $1.31 billion -- Thomson Reuters I/B/E/S.  Full Article

Icu Medical says termination rights in connection of Hospira deal include payment of $75 mln from Pfizer
Thursday, 13 Oct 2016 05:52pm EDT 

ICU Medical Inc : ICU Medical - Termination rights in connection of Hospira infusion systems deal include payment of $75 million from Pfizer under some conditions- SEC filing Source: (http://bit.ly/2e5kmnK) Further company coverage: [ICUI.O] ((bangalore.newsroom@thomsonreuters.com;)).  Full Article

ICU Medical sees 2016 adj earnings per share $4.45-$4.60
Monday, 8 Aug 2016 04:05pm EDT 

Icu Medical Inc : ICU Medical, Inc. Announces second quarter 2016 results . Q2 gaap earnings per share $0.98 . Q2 earnings per share view $1.05 -- Thomson Reuters I/B/E/S . Sees fy 2016 revenue $360 million to $370 million . Q2 adjusted earnings per share $1.15 . Q2 revenue $96.7 million versus i/b/e/s view $89.7 million . Sees fy 2016 adjusted earnings per share $4.45 to $4.60 .Fy2016 earnings per share view $4.43, revenue view $362.2 million -- Thomson Reuters I/B/E/S.  Full Article

ICU Medical Q1 GAAP earnings per share $0.96
Tuesday, 10 May 2016 04:05pm EDT 

ICU Medical Inc : Q1 adjusted earnings per share $1.14 . Q1 gaap earnings per share $0.96 . Q1 revenue $89.9 million versus I/B/E/S view $88 million . Sees fy 2016 adjusted earnings per share $4.34 to $4.46 . Sees fy 2016 revenue $355 million to $365 million . Q1 earnings per share view $1.01 -- Thomson Reuters I/B/E/S . Reiterating its 2016 guidance .Fy2016 earnings per share view $4.41, revenue view $362.3 million -- Thomson Reuters I/B/E/S.  Full Article

ICU Medical Inc gives FY 2016 outlook
Wednesday, 3 Feb 2016 04:10pm EST 

ICU Medical Inc:Says for FY 2016 , expects revenue to be in the range of $355 million to $365 million; adjusted diluted earnings per share to be in the range of $4.34 to $4.46, and adjusted EBITDA to be in the range of $123 million to $127 million.  Full Article

ICU Medical Inc board authorizes close of Slovakia manufacturing facility
Wednesday, 18 Nov 2015 07:40pm EST 

ICU Medical Inc:Says on November 16, board authorized company to close its vrable, Slovakia manufacturing facility.Says pre-tax charges are expected to be recorded primarily during the fourth quarter of 2015.Slovakia facility closure will result in a pre-tax restructuring charge to earnings of approximately $3.4 million.Says Slovakia facility closure will impact approximately 265 employees.Estimates that Slovakia facility closure will result in a pre-tax restructuring charge to earnings of approximately $3.4 million.Net cash outlays related to actions expected to be about $3.3 million to $5.7 million.Substantially all of net cash outlays related to actions expected to be paid during fiscal 2016.  Full Article

BRIEF-Medical Australia enters scheme implementation agreement

* Entered scheme implementation agreement under which it is proposed that ICU Medical Inc will acquire MLA